Riskpilot← Back to searchSign inGet full accessAllergiexperterna Sverige AB
ABIn liquidationOrg 5592587850Other human health activities n.e.c. · NACE 8699Est. 20200 employees
Revenue 2025
SEK 450K
-64% vs 2024
EBITDA margin
-30.7%
-138% vs 2024
Equity ratio
94.0%
Financial strength
Net profit 2025
SEK -60K
-128% vs 2024
| Revenue | SEK 450K | -64% |
| EBITDA | SEK -138K | -138% |
| Net profit | SEK -60K | -128% |
| Total assets | SEK 207K | -64% |
| Equity | SEK 194K | -55% |
| Employees | 0 | — |
Legal name
Allergiexperterna Sverige AB
Org number
5592587850
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
8 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Konsult- och utbildningsverksamhet inom sjuk- och hälsovård. Samt utveckling och försäljning av produkter inom sjuk- och hälsovård.
Address
Email
e.k.strand@sbsredovisning.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 108 | 12 | 782 | 1 234 | 450 |
| Staff expenses | — | −1 | −389 | −513 | −368 |
| EBITDA | — | −142 | 245 | 363 | −138 |
| Depreciation & amort. | −12 | −12 | −12 | −12 | −9 |
| EBIT | −12 | −154 | 233 | 351 | −147 |
| Net financials | — | −3 | −18 | 1 | 0 |
| Profit before tax | −12 | −158 | 216 | 265 | −60 |
| Tax | −0 | — | −9 | −54 | — |
| Net profit | −12 | −158 | 206 | 211 | −60 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 280 | 314 | 535 | 580 | 207 |
| Equity | 22 | 14 | 220 | 431 | 194 |
| Long-term debt | 0 | 200 | 193 | 0 | — |
| Short-term debt | 259 | 100 | 121 | 62 | 13 |
| Total debt | 259 | 300 | 315 | 62 | 13 |
EBITDA margin
-30.7%
This company
15.8%
Market median
-294% vs market
20212025
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
20212025
Return on equity
-30.9%
This company
18.4%
Market median
-268% vs market
20212025
Net profit margin
-13.4%
This company
8.1%
Market median
-265% vs market
20212025
Asset turnover
2.17×
This company
1.12×
Market median
+94% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EK Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Allergiexperterna Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eddi Kopare Strand | Liquidator | 0 companies |
| Siv Anna Britta Sandin | Board of Directors | 0 companies |
| Anna Elvira Augusta Sandin | Deputy Board Member | 0 companies |
| Linda Veronica Bedinger | Chairman | 0 companies |